PI
HRMY icon

Putnam Investments’s Harmony Biosciences HRMY Stock Holding History

Putnam Investments’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-109,547
Closed -$3.58M – 1177
2023
Q1 		$3.58M Sell
109,547
-25,965
-19% -$1.18M 0.01% 533
2022
Q4 		$7.47M Buy
135,512
+20,385
+18% +$1.12M 0.01% 346
2022
Q3 		$5.1M Buy
+115,127
New +$5.62M 0.01% 426

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Putnam Investments's HRMY Position: Q2 2023 in Review

Putnam Investments sold out of Harmony Biosciences (HRMY) in Q2 2023, closing a stake of 109,547 shares — an estimated $3.58M sold.

Putnam Investments first reported a position in HRMY in Q3 2022 and held it in 3 quarters. The position peaked at $7.47M in Q4 2022. 211 funds tracked by Wall St. Rank hold HRMY as of Q2 2023.

  • Putnam Investments reported no remaining Harmony Biosciences position as of Q2 2023 after selling out during the quarter.
  • Putnam Investments sold 109,547 Harmony Biosciences shares in Q2 2023, an estimated $3.58M.
  • Putnam Investments first reported a position in Harmony Biosciences in Q3 2022 and held it in 3 quarters.
  • Putnam Investments's Harmony Biosciences position peaked at $7.47M in Q4 2022.
  • 211 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2023.

Based on Putnam Investments's 13F filing for Q2 2023, filed 14 Aug 2023.